Location History:
- Old Lyme, CT (US) (2015 - 2017)
- Coventry, RI (US) (2018 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Keith Edward McCarthy: Innovator in Oxycodone Synthesis
Introduction
Keith Edward McCarthy is a prolific inventor based in Coventry, Rhode Island, holding a remarkable total of 10 patents. His contributions to the field of pharmaceutical synthesis, particularly around oxycodone, represent significant advancements in drug development and production methods.
Latest Patents
Among his latest innovations, McCarthy has developed a process for improved oxycodone synthesis. This patent outlines processes for preparing oxycodone, which include a critical step involving the hydrogenation of a 14-hydroxycodeinone salt under specific conditions, using trifluoroacetic acid and/or a glycol. This innovative approach is expected to enhance the efficiency and safety of oxycodone production.
Career Highlights
Working at Rhodes Technologies, Keith Edward McCarthy has established himself as a key player in his field. His ten patents reflect his dedication to innovation and improvement in drug synthesis methodologies, underscoring his importance in the pharmaceutical industry.
Collaborations
Throughout his career, McCarthy has collaborated with esteemed colleagues, including Joshua Robert Giguere and Marcel Schleusner. These collaborations have likely contributed to the advancements and refinements of the processes he has patented, showcasing his ability to work effectively within a team of skilled professionals.
Conclusion
Keith Edward McCarthy’s contributions to oxycodone synthesis and his impressive portfolio of patents have positioned him as a significant innovator in the pharmaceutical sector. His ongoing work at Rhodes Technologies, along with his collaborations, continues to pave the way for advancements in drug synthesis, demonstrating the vital role inventors play in the development of new and improved medical solutions.